Jacobs Levy Equity Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Sell |
455,451
-894,231
| -66% | -$65.6M | 0.13% | 160 |
|
|
2025
Q1 | $154M | Sell |
1,349,682
-27,199
| -2% | -$3.11M | 0.61% | 31 |
|
|
2024
Q4 | $69.4M | Buy |
1,376,881
+153,100
| +13% | +$7.71M | 0.25% | 100 |
|
|
2024
Q3 | $56.6M | Buy |
1,223,781
+352,947
| +41% | +$16.3M | 0.22% | 116 |
|
|
2024
Q2 | $28.3M | Buy |
870,834
+139,366
| +19% | +$4.53M | 0.12% | 180 |
|
|
2024
Q1 | $18.4M | Buy |
+731,468
| New | +$18.4M | 0.08% | 217 |
|
|
2020
Q4 | – | Sell |
-704,024
| Closed | -$12.3M | – | 1027 |
|
|
2020
Q3 | $12.3M | Sell |
704,024
-165,376
| -19% | -$2.88M | 0.13% | 179 |
|
|
2020
Q2 | $14.6M | Buy |
869,400
+371,270
| +75% | +$6.24M | 0.16% | 156 |
|
|
2020
Q1 | $5.92M | Buy |
+498,130
| New | +$5.92M | 0.08% | 264 |
|
|
2018
Q1 | – | Sell |
-49,310
| Closed | -$891K | – | 1008 |
|
|
2017
Q4 | $891K | Buy |
49,310
+29,500
| +149% | +$533K | 0.02% | 637 |
|
|
2017
Q3 | $382K | Buy |
+19,810
| New | +$382K | 0.01% | 746 |
|
|
2015
Q4 | – | Sell |
-16,200
| Closed | -$61K | – | 822 |
|
|
2015
Q3 | $61K | Buy |
+16,200
| New | +$61K | ﹤0.01% | 783 |
|